Radiopharmaceuticals for positron emission tomography methodological aspects by developments in nuclear medicine book 24 thanks for sharing you submitted the following rating and review well publish them on our site once weve reviewed them. 68 ga labeled radiopharmaceuticals for positron emission tomography 68 ga is a promising emerging radionuclide for positron emission tomography pet it is produced using a 68 ge 68 ga generator however new 68 ga labeled radiopharmaceuticals that can replace 18 f labeled agents like 18 ffluorodeoxyglucose fdg are needed. It brings together in one complete self contained volume a collection of monographs containing a wealth of practical information from across the literature demonstrating in meticulous detail how to prepare radiopharmaceuticals for positron emission tomography pet imaging especially in tumor studies cardiology and neuroscience. Positron emission tomography pet is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body as an aid to the diagnosis of disease the system detects pairs of gamma rays emitted indirectly by a positron emitting radionuclide most commonly fluorine 18 which is introduced into the body on a biologically active molecule called a radioactive tracer. 1 introductionone prerequisite to performing an investigation with positron emission tomography pet is the availability of a suitable radiopharmaceutical the selection preparation and preclinical evaluation of a new radiopharmaceutical is addressed by the field of radiopharmaceutical chemistry